Photo of Kevin Winthrop, M.D., M.P.H.

Kevin Winthrop M.D., M.P.H.

Dr. Winthrop specializes in international ophthalmology, public health and infectious disease epidemiology with an emphasis in mycobacterial diseases and opportunistic infections associated with rheumatic disease and immunosuppressive therapies. He has a special focus in:

Chronic chest infections of all etiology, including mycobacteria The prevention and treatment of infections associated with Biologics and other Immunosuppressive therapies Tuberculosis of the eye (Ophthalmology)

Read more

Education

  • M.D., Oregon Health & Science University, Portland Oregon 1998
  • M.P.H., Univerisity of California at Berkeley, Berkeley California 2003
  • Residency:

    • Stanford University
    • Legacy Emanuel Health Systems, Portland, Oregon
  • Fellowship:

    • National Jewish Medical Center, Denver, Colorado
    • US Centers for Disease Control and Prevention (CDC)

Publications

  • "Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis : a randomised clinical trial." Annals of the rheumatic diseases  In: , Vol. 76, No. 9, 01.09.2017, p. 1559-1565.
  • "Herpes zoster in psoriasis patients treated with tofacitinib." Journal of the American Academy of Dermatology  In: , Vol. 77, No. 2, 01.08.2017, p. 302-309.
  • "Frequency of untreated hypogammaglobulinemia in bronchiectasis." Annals of Allergy, Asthma and Immunology In: , Vol. 119, No. 1, 01.07.2017, p. 83-85.
  • "The role of IL-6 in host defence against infections : Immunobiology and clinical implications." Nature Reviews Rheumatology  In: , Vol. 13, No. 7, 01.07.2017, p. 399-409.
  • "Pharmacotherapy : Biosimilar switching-"To set a form upon desired change"." Nature Reviews Rheumatology In: , Vol. 13, No. 7, 01.07.2017, p. 391-392.
  • "Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years : Integrated analysis of data from the global clinical trials." Annals of the Rheumatic Diseases  In: , Vol. 76, No. 7, 01.07.2017, p. 1253-1262.
  • "The RESPIRE trials : Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis." Contemporary Clinical Trials  In: , Vol. 58, 01.07.2017, p. 78-85.
  • "Long-term outcomes in a population-based cohort with respiratory nontuberculous mycobacteria isolation." Annals of the American Thoracic Society In: , Vol. 14, No. 7, 01.07.2017, p. 1120-1128.
  • "Mortality after respiratory isolation of nontuberculous mycobacteria a comparison of patients who did and did not meet disease criteria." Annals of the American Thoracic Society In: , Vol. 14, No. 7, 01.07.2017, p. 1112-1119.
  • "Longterm effectiveness of herpes zoster vaccine among patients with autoimmune and inflammatory diseases." Journal of Rheumatology In: , Vol. 44, No. 7, 01.07.2017, p. 1083-1087.
  • "Adult Patients With Bronchiectasis : A First Look at the US Bronchiectasis Research Registry." Chest  In: , Vol. 151, No. 5, 01.05.2017, p. 982-992.
  • "Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis c virus infection." Journal of Rheumatology In: , Vol. 44, No. 5, 01.05.2017, p. 565-570.
  • "The emerging safety profile of JAK inhibitors in rheumatic disease." Nature Reviews Rheumatology In: , Vol. 13, No. 4, 01.04.2017, p. 234-243.
  • "Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease." American Journal of Respiratory and Critical Care Medicine In: , Vol. 195, No. 6, 15.03.2017, p. 814-823.
  • "Pulmonary nontuberculous mycobacteria-associated deaths, Ontario, Canada, 2001-2013." Emerging Infectious Diseases In: , Vol. 23, No. 3, 01.03.2017, p. 468-476.
  • "Disseminated nontuberculous mycobacteria in HIV-infected patients, Oregon, USA, 2007–2012." Emerging Infectious Diseases In: , Vol. 23, No. 3, 01.03.2017, p. 533-535.
  • "On the reportability of nontuberculous mycobacterial disease to public health authorities." Annals of the American Thoracic Society  In: , Vol. 14, No. 3, 01.03.2017, p. 314-317.
  • "Infection and Malignancy in Rheumatic Diseases." Rheumatic Disease Clinics of North America In: , Vol. 43, No. 1, 01.02.2017, p. xiii-xiv.
  • "Vaccines and Disease-Modifying Antirheumatic Drugs : Practical Implications for the Rheumatologist." Rheumatic Disease Clinics of North America In: , Vol. 43, No. 1, 01.02.2017, p. 1-13.
  • "Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases." Arthritis and Rheumatology In: , Vol. 69, No. 2, 01.02.2017, p. 439-446.
  • "Pathogens and antibiotic sensitivities in endophthalmitis." Clinical and Experimental Ophthalmology In: , 2017.
  • "The unmet need in rheumatology : Reports from the targeted therapies meeting 2017." Clinical Immunology In: , 2017.
  • "Treatments for lupus nephritis : A systematic review and network metaanalysis." Journal of Rheumatology In: , Vol. 43, No. 10, 01.10.2016, p. 1801-1815.
  • "Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases : Implications for Vaccination." Arthritis and Rheumatology In: , Vol. 68, No. 9, 01.09.2016, p. 2328-2337.
  • "Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection an NTM research consortium workshop report." Annals of the American Thoracic Society In: , Vol. 13, No. 9, 01.09.2016, p. S379-S384.
  • "Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis." Annals of the Rheumatic Diseases In: , 29.07.2016.
  • "Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis." Annals of the Rheumatic Diseases In: , 25.04.2016.
  • "Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK : A retrospective cohort study using data from the clinical practice research datalink." PLoS One In: , Vol. 11, No. 4, e0153848, 01.04.2016.
  • "Vaccinations for rheumatoid arthritis." Current Opinion in Rheumatology  In: , 16.03.2016.
  • "Treatment of mycobacterium abscessus infection." Emerging Infectious Diseases In: , Vol. 22, No. 3, 01.03.2016, p. 511-514.

Additional information

Edit profile